Walk into any supplement shop and you will find bottles labeled NAD+, NMN, or NR, sitting a few shelves from the vitamins. Elsewhere, a clinic offers NAD+ by injection, drops, or nasal spray on a prescription. The names overlap enough that they look like the same product at different prices.

They are not the same product. The difference is not marketing, and it is not mainly about strength. It is about what molecule is actually in the bottle and how it gets into your cells.

This article is educational and not medical advice.

What is actually being sold

Over the counter you are almost always buying a precursor, not NAD+ itself. The two common ones are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Both are forms of vitamin B3 chemistry that the body converts along a pathway toward NAD+. Plain nicotinamide and nicotinic acid are also sold as precursors.

By prescription, preparations of NAD+ itself are available in forms that bypass the digestive tract: injection, intravenous infusion, sublingual or oral drops, and nasal spray. These are compounded preparations.

So the shelf and the clinic are often not offering the same molecule at all.

Precursors versus the coenzyme itself

NAD+ is a coenzyme. It is the molecule that NAD+-dependent enzymes require to do their work, in processes including DNA repair, cellular metabolism, and immune function [1].

Here is the mechanistic problem. NAD+ is a pyridine nucleotide, and in that intact form it does not readily cross the intestinal wall or pass into a cell [2]. Swallowing NAD+ itself is therefore an inefficient way to deliver NAD+.

What happens instead is that at higher concentrations outside the cell, NAD+ is broken down into smaller components, including NMN and NR, which do have dedicated transporters and can enter cells directly [1]. In other words, some of the NAD+ you administer works by becoming a precursor anyway.

That cuts both ways, and it is the honest version of this comparison:

  • Precursors are built for the journey. NR and NMN are smaller and have transport routes into cells. That is an argument for the supplement side, not against it.
  • But oral delivery is lossy. Orally administered NR is rapidly converted to nicotinamide in the gut and liver, and is reported to be undetectable in the bloodstream within about an hour [3]. Much of what you swallow does not arrive as what you swallowed.
  • Injected and infused routes skip the gut entirely. That is the actual argument for the prescription forms, and it is a delivery argument rather than a potency one.

What the bioavailability research shows, including its limits

Oral precursors do raise measurable blood NAD+. An eight-week randomized, double-blind, placebo-controlled trial of nicotinamide riboside at 100, 300, and 1,000 mg daily found dose-dependent increases in whole blood NAD+ of 22, 51, and 142 percent, reached within two weeks and maintained [4]. Oral NMN has also been reported to raise whole blood NAD+ in a dose-dependent way across studied ranges.

Intravenous routes have been studied less than their popularity suggests. Systematic investigation of the safety and tolerability of intravenous NAD+ remains limited despite widespread commercial use [5]. Reported adverse experiences include nausea, diarrhea, muscle cramping, chest discomfort, and dizziness, closely tied to infusion rate [5].

Route can matter more than amount. In a comparison at the same 500 mg dose, nicotinamide riboside given intravenously had a faster infusion time and better tolerability than NAD+ given intravenously, and blood NAD+ three hours afterward was higher in the NR group [2]. Identical number, different outcome.

The honest limitation. Almost all of this research measures blood NAD+ levels. That is a measurement of the molecule, not of how a person feels or functions. Raising a biomarker and producing a clinical benefit are two separate claims, and the second one is far less well established than the first. Anyone presenting a percentage increase in blood NAD+ as if it were an outcome is skipping a step.

Regulatory status on both sides

This is messier than either side of the market usually admits.

On the supplement side, NMN has had a turbulent history. The FDA stated in late 2022 that NMN was excluded from the definition of a dietary supplement under the drug preclusion provision, because it had previously been investigated as a drug. Following a citizen petition, the agency reversed that position in late 2025, and NMN is once again lawfully marketable as a dietary supplement subject to the standard new dietary ingredient notification rules [6]. NR has not had that history.

Supplements are not reviewed by the FDA for effectiveness before sale, and manufacturing quality varies between products.

On the prescription side, compounded NAD+ preparations are not FDA-approved, and the FDA does not evaluate compounded drugs for safety, effectiveness, or quality. NAD+'s compounding status is also unsettled: the Pharmacy Compounding Advisory Committee recommended against including it on the relevant bulk substances list, and the FDA has proposed not listing it. Nobody should describe that question as resolved.

Neither side of this comparison has a clean regulatory story. Anyone telling you one does is selling.

Why prescription forms involve a provider

The difference is not that a prescription preparation is inherently stronger. It is that the decisions around it are clinical ones.

Dose is individualized. Studied amounts differ enormously by route: oral studies have used up to 1,000 mg or more daily, while injected studies have used 50 to 100 mg [4, 7]. Those numbers do not translate across routes, and picking among them is not a consumer decision.

Titration and adjustment. Tolerability is the limiting factor for the infused and injected routes, and it is managed by adjusting the amount and the rate over time rather than by setting a number once.

Interactions and history. A licensed provider reviews your other medications and your health history before anything is prescribed. That review is the substantive difference between the two categories.

Like anything prescribed, these preparations carry possible side effects, and a provider will go through those with you.

On testing. Luvo does not run labs. If bloodwork is clinically relevant, it is arranged through your own provider or physician. Be wary of any service that sells you a NAD+ level test as the entry point: measuring blood NAD+ is a research endpoint, not a standard clinical measure used to set an individual dose.

How to decide: questions worth asking a clinician

Rather than picking a side, bring these:

  • What is my actual goal here, and is there evidence that any of these affects it?
  • Given my health history and medications, is there a reason to avoid either route?
  • If we start with an oral precursor, what would tell us whether to continue?
  • If a prescription form is suggested, what dose and schedule, and what is that based on?
  • What would make you recommend stopping?

That last one is the most useful question in the list, and the one least often asked.

Common questions

Are NMN and NAD+ the same thing?

No. NMN is a precursor, a smaller molecule the body converts along the pathway toward NAD+. NAD+ is the coenzyme itself. They are related steps in the same pathway, not interchangeable products.

Do oral supplements actually raise NAD+ levels?

In published trials, yes, as measured in whole blood. Nicotinamide riboside at 100, 300, and 1,000 mg daily produced dose-dependent increases of 22, 51, and 142 percent over eight weeks [4]. What is much less established is what those blood level changes mean for how someone feels or functions. Those are different questions and the evidence for the second is weaker.

Is prescription NAD+ FDA-approved?

No. Compounded NAD+ preparations are not FDA-approved, and the FDA does not evaluate compounded drugs for safety, effectiveness, or quality. The agency has also proposed not listing NAD+ on the relevant bulk substances list, so its compounding status is unsettled rather than settled.

Can I combine a supplement and an injection?

That is a question for the provider managing your care, not something to decide on your own. They need to know everything you are taking, including anything over the counter, before adding to it.

Next steps

If any of this sounds like what you are dealing with, the next step is a conversation with a licensed provider who can review your history and decide whether treatment makes sense for you. Nothing is prescribed or shipped without that review.

Explore Luvo's Longevity Program.

Sources

  1. Reyna K, Heinzen G, Patel N, et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Frontiers in Aging. 2026. DOI: 10.3389/fragi.2026.1652582
  2. Nikiforov A, et al. Pathways and subcellular compartmentation of NAD biosynthesis in human cells. Journal of Biological Chemistry. 2011;286:21767-21778.
  3. Oral delivery of carrier-free dual-drug nanocrystal self-assembled microspheres improved NAD+ bioavailability. PMC7899691. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899691/
  4. Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of nicotinamide riboside chloride in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Scientific Reports. 2019;9:9772. PMC6611812
  5. Randomized, placebo-controlled, pilot clinical study evaluating acute NR IV and NAD+ IV in healthy adults. medRxiv. 2024. DOI: 10.1101/2024.06.06.24308565
  6. US Food and Drug Administration, December 2025 letters to NDI notifiers confirming that NMN is not excluded from the dietary supplement definition, reversing the November 2022 determination.
  7. Preliminary safety analysis of two pilot clinical trials involving injections of nicotinamide riboside chloride. medRxiv. 2026. DOI: 10.64898/2026.04.28.26352007

This article is for general educational purposes and is not medical advice. It is not a substitute for a conversation with a licensed healthcare provider about your own health. Prescription treatments require provider review and approval. Individual results vary.

Compounded medications are prepared by a licensed compounding pharmacy and are not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness, or quality. Combination formulations are not approved as combinations.